NEUROSTAR
Received Jul 16, 2025
Report 3004824012-2025-00039 · MDR key 22522724
Device
Generic name
Tms
Manufacturer
Neuronetics, Inc.Product problems
- Patient-Device Incompatibility
- Patient-Device Incompatibility
Patient
NA · Female
- Headache
- Nausea
- Headache
- Nausea
Narrative
Description of Event or Problem
NEURONETICS' SOCIAL MEDIA MONITOR FORWARDED A POST ALLEGING TMS TREATMENT CAUSED SEVERE MIGRAINES AND NAUSEA.
Additional Manufacturer Narrative
SINCE THE REPORTER DID NOT RESPOND TO NEURONETICS' ATTEMPTED OUTREACH FOR ADDITIONAL INFORMATION, IT WAS IMPOSSIBLE TO CONDUCT A THOROUGH INVESTIGATION AND CONFIRM THAT THE PERSON WAS TREATED WITH A NEUROSTAR DEVICE. BASED ON THE INFORMATION PROVIDED NO CAUSE CAN BE ATTRIBUTED BUT REPORTING OUT OF AN ABUNDANCE OF CAUTION. NOTE - THIS WAS ORIGINALLY ATTEMPTED TO BE SUBMITTED ON 5/20/25 BUT WAS FOUND TO HAVE NOT SUCCESSFULLY BEEN TRANSMITTED FROM ESUBMITTER. IT IS NOW BEING RESUBMITTED ON 7/16/25 AFTER RECEIVING GUIDANCE FROM FDA ESG/MDR TEAM AND RENUMBERING THE MDR (INITIALLY 3004824012-2025-00017).